FDA Inspection 1301468 — Fujian Genohope Biotech Ltd
The FDA completed an inspection of Fujian Genohope Biotech Ltd on January 16, 2026 in Futian. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 16, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Futian (China)